KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Shares Outstanding (Weighted Average): 2009-2025

Historic Shares Outstanding (Weighted Average) for Novavax (NVAX) over the last 17 years, with Sep 2025 value amounting to $162.4 million.

  • Novavax's Shares Outstanding (Weighted Average) rose 1.45% to $162.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.4 million, marking a year-over-year increase of 1.45%. This contributed to the annual value of $160.2 million for FY2024, which is 34.85% up from last year.
  • According to the latest figures from Q3 2025, Novavax's Shares Outstanding (Weighted Average) is $162.4 million, which was up 0.28% from $162.0 million recorded in Q2 2025.
  • Over the past 5 years, Novavax's Shares Outstanding (Weighted Average) peaked at $162.4 million during Q3 2025, and registered a low of $73.9 million during Q1 2021.
  • For the 3-year period, Novavax's Shares Outstanding (Weighted Average) averaged around $133.8 million, with its median value being $140.4 million (2024).
  • Data for Novavax's Shares Outstanding (Weighted Average) shows a peak YoY spiked of 69.58% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Novavax's Shares Outstanding (Weighted Average) stood at $75.6 million in 2021, then grew by 3.83% to $78.5 million in 2022, then spiked by 51.32% to $118.8 million in 2023, then skyrocketed by 34.85% to $160.2 million in 2024, then rose by 1.45% to $162.4 million in 2025.
  • Its last three reported values are $162.4 million in Q3 2025, $162.0 million for Q2 2025, and $160.8 million during Q1 2025.